{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:21:14Z","timestamp":1792668074987,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA-3975\/2-1"],"award-info":[{"award-number":["MA-3975\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["DKH-JvM-861005"],"award-info":[{"award-number":["DKH-JvM-861005"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncolytics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.omto.2019.12.011","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:59:02Z","timestamp":1578686342000},"page":"134-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Wnt7a Counteracts Cancer Cachexia"],"prefix":"10.1016","volume":"16","author":[{"given":"Manuel","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Poser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"von Maltzahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2019.12.011_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omto.2019.12.011_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.omto.2019.12.011_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J.\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omto.2019.12.011_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/bmj.315.7117.1219","article-title":"ABC of palliative care. Anorexia, cachexia, and nutrition","volume":"315","author":"Bruera","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.omto.2019.12.011_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/cncy.21810","article-title":"Cancer Cytopathology enters its third decade","volume":"125","author":"Powers","year":"2017","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.omto.2019.12.011_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.critrevonc.2018.05.006","article-title":"Cancer cachexia: diagnosis, assessment, and treatment","volume":"127","author":"Sadeghi","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.omto.2019.12.011_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12885-016-2121-8","article-title":"Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?","volume":"16","author":"Mueller","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omto.2019.12.011_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/529156b","article-title":"Cachexia: treat wasting illness on multiple fronts","volume":"529","author":"Fearon","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omto.2019.12.011_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.omto.2019.12.011_bib10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/1440-1681.12559","article-title":"Skeletal muscle regeneration in cancer cachexia","volume":"43","author":"Bossola","year":"2016","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.omto.2019.12.011_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10409238.2013.857291","article-title":"Signaling pathways controlling skeletal muscle mass","volume":"49","author":"Egerman","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.omto.2019.12.011_bib12","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.omto.2019.12.011_bib13","first-page":"267","article-title":"PI3 kinase regulation of skeletal muscle hypertrophy and atrophy","volume":"346","author":"Glass","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.omto.2019.12.011_bib14","first-page":"183","article-title":"What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?","volume":"4","author":"Jagoe","year":"2001","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.omto.2019.12.011_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omto.2019.12.011_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2019.12.011_bib17","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.25146","article-title":"Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?","volume":"127","author":"Penna","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omto.2019.12.011_bib18","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omto.2019.12.011_bib19","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"He","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omto.2019.12.011_bib20","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00018-019-03093-6","article-title":"Adult stem cells at work: regenerating skeletal muscle","volume":"76","author":"Schmidt","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omto.2019.12.011_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature13013","article-title":"Geriatric muscle stem cells switch reversible quiescence into senescence","volume":"506","author":"Sousa-Victor","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omto.2019.12.011_bib22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.tcb.2012.07.008","article-title":"Wnt signaling in myogenesis","volume":"22","author":"von Maltzahn","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.omto.2019.12.011_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20091866","article-title":"Wnt signalling and the control of cellular metabolism","volume":"427","author":"Sethi","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.omto.2019.12.011_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/cr.2008.47","article-title":"Wnt signaling and stem cell control","volume":"18","author":"Nusse","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.omto.2019.12.011_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signalling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omto.2019.12.011_bib26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.omto.2019.12.011_bib27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2009.03.013","article-title":"Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells","volume":"4","author":"Le Grand","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omto.2019.12.011_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.stem.2012.09.015","article-title":"Fibronectin regulates Wnt7a signaling and satellite cell expansion","volume":"12","author":"Bentzinger","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omto.2019.12.011_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13395-015-0038-6","article-title":"Wnt\/\u03b2-catenin controls follistatin signalling to regulate satellite cell myogenic potential","volume":"5","author":"Jones","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omto.2019.12.011_bib30","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2007.03.044","article-title":"Asymmetric self-renewal and commitment of satellite stem cells in muscle","volume":"129","author":"Kuang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.omto.2019.12.011_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1083\/jcb.201310035","article-title":"Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength","volume":"205","author":"Bentzinger","year":"2014","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omto.2019.12.011_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ncb2404","article-title":"Wnt7a-Fzd7 signalling directly activates the Akt\/mTOR anabolic growth pathway in skeletal muscle","volume":"14","author":"von Maltzahn","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omto.2019.12.011_bib33","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/ncomms3869","article-title":"A truncated Wnt7a retains full biological activity in skeletal muscle","volume":"4","author":"von Maltzahn","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omto.2019.12.011_bib34","doi-asserted-by":"crossref","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","article-title":"A key role for leukemia inhibitory factor in C26 cancer cachexia","volume":"290","author":"Seto","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2019.12.011_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12154-008-0003-5","article-title":"Rapamycin and mTOR kinase inhibitors","volume":"1","author":"Ballou","year":"2008","journal-title":"J.\u00a0Chem. Biol."},{"key":"10.1016\/j.omto.2019.12.011_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00424-010-0919-9","article-title":"The role and regulation of MAFbx\/atrogin-1 and MuRF1 in skeletal muscle atrophy","volume":"461","author":"Foletta","year":"2011","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.omto.2019.12.011_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13395-019-0193-2","article-title":"IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omto.2019.12.011_bib38","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1042\/BJ4731111","article-title":"Retraction","volume":"473","author":"Lokireddy","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.omto.2019.12.011_bib39","doi-asserted-by":"crossref","first-page":"C1239","DOI":"10.1152\/ajpcell.00431.2010","article-title":"Physiological and histological changes in skeletal muscle following in\u00a0vivo gene transfer by electroporation","volume":"301","author":"Roche","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.omto.2019.12.011_bib40","doi-asserted-by":"crossref","first-page":"20614","DOI":"10.1073\/pnas.1215765109","article-title":"Wnt7a treatment ameliorates muscular dystrophy","volume":"109","author":"von Maltzahn","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omto.2019.12.011_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/7651_2019_209","article-title":"Isolation and culture of individual myofibers and their adjacent muscle stem cells from aged and adult skeletal muscle","volume":"2045","author":"H\u00fcttner","year":"2019","journal-title":"Methods Mol. Biol."}],"container-title":["Molecular Therapy Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520300036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520300036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:11:15Z","timestamp":1784808675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770520300036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":41,"alternative-id":["S2372770520300036"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2019.12.011","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wnt7a Counteracts Cancer Cachexia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2019.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}